Fluo Labs, Inc. is a premarket clinical stage medical device company pursuing innovative technology to provide drug-free relief of nasal allergy (i.e. hay fever) symptoms. Fluo Labs is seeking to complete product development, clinical evaluation and obtain an FDA De Novo grant to help allergy sufferers reduce their allergy symptoms without having to use medication. The Fluo device is not yet FDA approved and is not available for sale in the United States.